14-day Premium Trial Subscription Sign Up For FreeGet Free

When Should You SELL Your Stocks? Click to watch.

AcelRx Pharmaceuticals Stock Forecast

NASDAQ:ACRX BUY SELL

$0.26 (-11.83%)

Volume: 1.5M

Closed: May 20, 2022

Hollow Logo Score: -1.213

AcelRx Pharmaceuticals Stock Forecast

BUY SELL NASDAQ:ACRX
$0.26 (-11.83%)

Volume: 1.5M

Closed: May 20, 2022

Score Hollow Logo -1.213

AcelRx Pharmaceuticals Stock Price (Quote) NASDAQ:ACRX

$0.26 ( -11.83% ) Friday, 20th May 2022

Range Low Price High Price Comment
30 days $0.16 $0.31 Friday, 20th May 2022 ACRX stock ended at $0.26. This is 11.83% less than the trading day before Thursday, 19th May 2022. During the day the stock fluctuated 18.87% from a day low at $0.25 to a day high of $0.30.
90 days $0.16 $0.48
52 weeks $0.16 $1.67

Historical AcelRx Pharmaceuticals prices

Date Open High Low Close Volume
2022-05-20 $0.29 $0.30 $0.25 $0.26 1 499 523
2022-05-19 $0.23 $0.31 $0.23 $0.29 4 014 051
2022-05-18 $0.22 $0.23 $0.22 $0.23 565 269
2022-05-17 $0.22 $0.22 $0.21 $0.22 388 523
2022-05-16 $0.19 $0.21 $0.19 $0.21 667 786
2022-05-13 $0.22 $0.22 $0.18 $0.21 1 192 980
2022-05-12 $0.19 $0.19 $0.16 $0.18 1 523 726
2022-05-11 $0.20 $0.21 $0.18 $0.19 1 313 868
2022-05-10 $0.23 $0.24 $0.20 $0.21 1 380 723
2022-05-09 $0.24 $0.24 $0.21 $0.21 1 067 791
2022-05-06 $0.22 $0.25 $0.21 $0.25 1 968 223
2022-05-05 $0.23 $0.24 $0.20 $0.21 1 007 506
2022-05-04 $0.24 $0.25 $0.22 $0.22 982 135
2022-05-03 $0.25 $0.26 $0.23 $0.23 791 100
2022-05-02 $0.26 $0.26 $0.24 $0.24 480 911
2022-04-29 $0.24 $0.25 $0.24 $0.25 695 439
2022-04-28 $0.25 $0.25 $0.23 $0.24 632 139
2022-04-27 $0.24 $0.26 $0.23 $0.24 678 811
2022-04-26 $0.24 $0.25 $0.22 $0.24 825 995
2022-04-25 $0.24 $0.25 $0.24 $0.24 460 159
2022-04-22 $0.25 $0.25 $0.23 $0.24 201 346
2022-04-21 $0.25 $0.26 $0.24 $0.24 764 900
2022-04-20 $0.26 $0.27 $0.25 $0.26 397 500
2022-04-19 $0.26 $0.28 $0.24 $0.27 1 147 100
2022-04-18 $0.26 $0.26 $0.25 $0.25 844 700
2022-04-14 $0.28 $0.28 $0.25 $0.26 956 520
2022-04-13 $0.27 $0.28 $0.26 $0.27 849 445
2022-04-12 $0.27 $0.27 $0.25 $0.27 895 864
2022-04-11 $0.27 $0.28 $0.25 $0.27 1 814 968
2022-04-08 $0.27 $0.28 $0.27 $0.27 369 151
2022-04-07 $0.30 $0.30 $0.27 $0.27 588 300
2022-04-06 $0.29 $0.29 $0.27 $0.28 909 700
2022-04-05 $0.29 $0.32 $0.28 $0.29 1 866 700
2022-04-04 $0.30 $0.30 $0.28 $0.29 592 100
2022-04-01 $0.29 $0.30 $0.28 $0.28 1 031 299
2022-03-31 $0.28 $0.29 $0.28 $0.29 1 007 097
2022-03-30 $0.30 $0.30 $0.25 $0.29 4 021 141
2022-03-29 $0.30 $0.32 $0.27 $0.28 5 117 493
2022-03-28 $0.31 $0.32 $0.29 $0.30 1 844 200
2022-03-25 $0.32 $0.33 $0.31 $0.32 570 400
2022-03-24 $0.32 $0.34 $0.31 $0.32 1 414 200
2022-03-23 $0.33 $0.34 $0.32 $0.32 987 900
2022-03-22 $0.34 $0.36 $0.32 $0.33 1 105 957
2022-03-21 $0.35 $0.35 $0.32 $0.33 825 151
2022-03-18 $0.35 $0.38 $0.32 $0.32 1 188 997
2022-03-17 $0.34 $0.36 $0.34 $0.36 932 300
2022-03-16 $0.32 $0.34 $0.31 $0.33 820 600
2022-03-15 $0.31 $0.32 $0.30 $0.31 911 000
2022-03-14 $0.35 $0.35 $0.29 $0.32 2 033 600
2022-03-11 $0.38 $0.40 $0.32 $0.34 2 962 200

About AcelRx Pharmaceuticals

AcelRx Pharmaceuticals AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of acute pain in the United States. The company’s lead product candidates include ARX-04, a sufentanil sublingual tablet that is in Phase III clinical trials for the treatment of moderate-to-severe acute pain to be administered by a healthcare professional to a patient in medically supervised settings; and Zalviso, a sufentan... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT